ProCertus Raises Series A

ProCertus BioPharm Inc., a Madison, Wis.-based developer of therapeutics to protect cancer patients against the side effects of chemotherapy and radiotherapy, has raised $2.3 million in Series A funding. Venture Investors LLC was joined by seed backer Novartis Venture Fund. www.procertus.com